Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma

Hee Jeong Cho; Jae-Cheol Jo; Yoo Jin Lee; Myung Won Lee; Do Young Kim; Ho Jin Shin; Sung Nam Im; Ji Hyun Lee; Sung Hwa Bae; Young Rok Do; Won Sik Lee; Min Kyung Kim; Jina Jung; Jung Min Lee; Ju-Hyung Kim; Dong Won Baek; Sang-Kyun Sohn; Joon Ho Moon

doi:10.3904/kjim.2022.183e

Erratum

The Korean Journal of Internal Medicine 2023;38(4):578.

Published online: June 09, 2023

DOI: https://doi.org/10.3904/kjim.2022.183e

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma

Hee Jeong Cho¹, Jae-Cheol Jo², Yoo Jin Lee², Myung Won Lee³, Do Young Kim⁴, Ho Jin Shin⁴, Sung Nam Im⁵, Ji Hyun Lee⁶, Sung Hwa Bae⁷, Young Rok Do⁸, Won Sik Lee⁹, Min Kyung Kim¹⁰, Jina Jung¹, Jung Min Lee¹, Ju-Hyung Kim¹, Dong Won Baek¹, Sang-Kyun Sohn¹, Joon Ho Moon¹

¹Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea

²Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

³Department of Hematology-Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea

⁴Department of Hematology-Oncology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea

⁵Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea

⁶Department of Hematology-Oncology, Dong-A University Hospital, Busan, Korea

⁷Department of Hematology-Oncology, Daegu Catholic University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea

⁸Department of Hematology-Oncology, Keimyung University School of Medicine, Daegu, Korea

⁹Department of Hematology-Oncology, Inje University Busan Paik Hospital, Busan, Korea

¹⁰Department of Hematology-Oncology, Yeungnam University Hospital, Daegu, Korea

Correspondence to: Joon Ho Moon, M.D., Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea, Tel: +82-53-200-6314, Fax: +82-53-426-2046, E-mail: jhmoon@knu.ac.kr, https://orcid.org/0000-0003-3756-796X

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This corrects the article "Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma" in volume 38 on page 238.

Korean J Intern Med 2023;38:238-247

https://doi.org/10.3904/kjim.2022.183

In the article cited above, there was an error in the chart legend in Supplementary Fig. 4. The corrected legend is as following:

Before:		Paients with ALC^D56 ≤ 700
		Paients with ALC^D56 > 700
After:		Paients with ALC^D56 > 700
		Paients with ALC^D56 ≤ 700

We apologize for any inconvenience that this may have caused.